Holen Sie sich die Stockscreener-App
20.73
5.39%
-1.18
Vorhandelsmarkt:
20.92
0.19
+0.92%
Schlusskurs vom Vortag:
$21.91
Offen:
$21.87
24-Stunden-Volumen:
1.29M
Relative Volume:
0.80
Marktkapitalisierung:
$1.19B
Einnahmen:
$322.02M
Nettoeinkommen (Verlust:
$-102.47M
KGV:
-11.33
EPS:
-1.8295
Netto-Cashflow:
$-80.57M
1W Leistung:
-5.56%
1M Leistung:
+7.86%
6M Leistung:
-23.98%
1J Leistung:
-47.36%
1-Tages-Spanne:
$20.69
$21.90
1-Wochen-Bereich:
$20.69
$22.20
52-Wochen-Spanne:
$16.66
$42.43
Procept Biorobotics Corp Stock (PRCT) Company Profile
Firmenname
Procept Biorobotics Corp
Sektor
Branche
Telefon
(650) 232-9832
Adresse
150 BAYTECH DRIVE, SAN JOSE
Compare PRCT vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PRCT
Procept Biorobotics Corp
|
20.73 | 1.25B | 322.02M | -102.47M | -80.57M | -1.8295 |
ABT
Abbott Laboratories
|
114.14 | 198.01B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
327.70 | 130.41B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
92.30 | 120.48B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
49.37 | 75.37B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
89.83 | 53.19B | 6.30B | 1.07B | 1.09B | 1.8406 |
Procept Biorobotics Corp Stock (PRCT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-06 | Eingeleitet | Robert W. Baird | Neutral |
| 2026-02-26 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2026-02-26 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2025-12-12 | Eingeleitet | UBS | Buy |
| 2025-12-08 | Herabstufung | BofA Securities | Buy → Neutral |
| 2025-09-02 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2025-07-09 | Eingeleitet | Stephens | Overweight |
| 2025-07-07 | Eingeleitet | Oppenheimer | Perform |
| 2024-12-02 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-11-14 | Eingeleitet | Jefferies | Hold |
| 2023-08-11 | Eingeleitet | Piper Sandler | Overweight |
| 2023-05-31 | Eingeleitet | William Blair | Outperform |
| 2022-10-31 | Eingeleitet | BTIG Research | Neutral |
| 2022-10-25 | Eingeleitet | Truist | Buy |
| 2022-09-02 | Eingeleitet | Wells Fargo | Overweight |
| 2022-07-15 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2022-06-23 | Eingeleitet | B. Riley Securities | Buy |
| 2021-10-11 | Eingeleitet | BofA Securities | Buy |
| 2021-10-11 | Eingeleitet | Cowen | Outperform |
| 2021-10-11 | Eingeleitet | Goldman | Neutral |
| 2021-10-11 | Eingeleitet | Guggenheim | Buy |
| 2021-10-11 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Procept Biorobotics Corp Aktie (PRCT) Neueste Nachrichten
PROCEPT BioRobotics Corporation $PRCT Shares Purchased by Bank of America Corp DE - MarketBeat
Kaplan Fox & Kilsheimer LLP Encourages PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Investors to Contact the Firm Before September 22, 2026 - The Globe and Mail
Deadline Alert: PROCEPT BioRobotics Corporation (PRCT) - GlobeNewswire
PRCT DEADLINE: SueWallSt Reminds PROCEPT BIOROBOTICS CORPORATION Investors of Upcoming Securities Class Action Deadline - PR Newswire
PRCT INVESTOR DEADLINE: RGRD Law Files Class Action Lawsuit Against PROCEPT BioRobotics Corporation and Announces Opportunity for Investors with Substantial Losses to Lead Class Action Lawsuit Before September 22, 2026 Deadline - marketscreener.com
PRCT INVESTOR DEADLINE: RGRD Law Files Class Action Lawsuit - GlobeNewswire
PROCEPT BioRobotics Shareholder Alert: ClaimsFiler Reminds - GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in PROCEPT BioRobotics Corporation of Class Action Lawsuit and Upcoming DeadlinesPRCT - PR Newswire
PROCEPT BioRobotics Corporation (PRCT) Investors: September 22, 2026 Lead Plaintiff Deadline in Class Action Lawsuit - TradingView
PROCEPT BIOROBOTICS CORPORATION (PRCT) SHAREHOLDER ALERT - GlobeNewswire
PRCT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that PROCEPT BioRobotics Corporation Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
PRCT DEADLINE: Levi & Korsinsky Reminds PROCEPT BIOROBOTICS CORPORATION Investors of Upcoming Securities Class Action Deadline - YCharts
PROCEPT BioRobotics Corporation Securities Fraud Class Action Result of Undisclosed Inventory Issues and approximately 18% Stock DeclineInvestors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC - TMX Newsfile
PRCT INVESTOR REMINDER: PROCEPT BioRobotics Corporation Investors Have Until September 22, 2026 To Contact Kirby McInerney LLP to Seek Lead Plaintiff Role - Business Wire
Kaplan Fox Announces a Securities Class Action Filed Against PROCEPT BioRobotics Corporation (NASDAQ: PRCT)Lead Plaintiff Deadline is September 22, 2026 - The Globe and Mail
PROCEPT BioRobotics Corporation Securities Fraud Class Action Result of Undisclosed Inventory Issues and Approximately 18% Stock DeclineInvestors May Contact Reed Kathrein at Hagens Berman Sobol Shapiro LLP - TMX Newsfile
Attention Long-Term Shareholders of AeroVironment, Inc. - GlobeNewswire
PRCT SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that PROCEPT BioRobotics Corporation Shareholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
PRCT DEADLINE ALERT: ROSEN, LEADING INVESTOR COUNSEL, Encourages PROCEPT BioRobotics ... - Caledonian Record
PRCT DEADLINE ALERT: ROSEN, LEADING INVESTOR COUNSEL, - GlobeNewswire
Procept BioRobotics CEO Buys 23,900 Shares Amid 48% Stock Decline. What Does This Tell Investors? - The Motley Fool
Procept BioRobotics CEO Buys 23,900 Shares Amid 48% Stock Decline. What Does This Tell Investors? - The Motley Fool
PROCEPT BioRobotics Corporation (PRCT) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
The Gross Law Firm Reminds PROCEPT BioRobotics Corporation Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of September 22, 2026PRCT - Morningstar
PRCT SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Anno - The National Law Review
Kaplan Fox Encourages Investors of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) to Contact the Firm Before Lead Plaintiff Deadline on September 22, 2026 - The Globe and Mail
PRCT Investors Have Opportunity to Lead PROCEPT BioRobotics Corporation Securities Fraud Lawsuit with SBS Law - GlobeNewswire
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against PROCEPT BioRobotics Corporation (PRCT) - TMX Newsfile
Attention Long-Term Shareholders of Cogent Communications - GlobeNewswire
PRCT INVESTOR ALERT: PROCEPT BioRobotics Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - PR Newswire
PROCEPT BioRobotics(R) to Attend the Baird 2026 Global Healthcare Conference on September 15, 2026 - marketscreener.com
GSA Capital Partners LLP Purchases New Position in PROCEPT BioRobotics Corporation $PRCT - MarketBeat
PRCT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that PROCEPT BioRobotics Corporation Stockholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
PROCEPT BioRobotics Corporation (PRCT) Investors: September - GlobeNewswire
Robbins LLP Encourages PRCT Shareholders With Significant Losses to Contact the Firm for Information About the Class Action Against PROCEPT BioRobotics Corporation - Business Wire
Kaplan Fox Encourages Investors of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) to Contact the Firm to Learn About Their Legal Rights - The Globe and Mail
Deadline Alert: PROCEPT BioRobotics Corporation (PRCT) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit - GlobeNewswire
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff - GlobeNewswire
Kaplan Fox Alerts PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Investors Who Suffered Losses to a Securities Class Action – Deadline is September 22, 2026 - The Spec
PROCEPT BioRobotics® to Attend the Baird 2026 Global Healthcare Conference on September 15, 2026 - The Manila Times
The Bull Case For PROCEPT BioRobotics (PRCT) Could Change Following Q2 Losses Amid Strong Revenue Growth - simplywall.st
PRCT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that PROCEPT BioRobotics Corporation Shareholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
PRCT Deadline: PRCT Investors with Losses in Excess of $100K Have Opportunity to Lead PROCEPT BioRobotics Corporation Securities Fraud Lawsuit - PR Newswire
Johnson & Johnson Invests $8.08 Billion in PROCEPT BioRobotics Corporation $PRCT - MarketBeat
PROCEPT BioRobotics Investors: September 22, 2026, Deadline in Securities Fraud Class Action Lawsuit - NewMediaWire
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages PROCEPT BioRobotics Corporation Investors to Secure ... - Caledonian Record
PROCEPT BioRobotics EVP Alaleh Nouri Granted 22,965 RSUs and Stock Options for 31,773 Shares - Kalkine Media
PROCEPT BioRobotics CTO Barry Templin Awarded RSUs and Stock Options in Advance of 2027 Grants - Kalkine Media
PROCEPT BioRobotics (PRCT) awards RSUs and stock options to EVP and CLO - Stock Titan
PROCEPT BioRobotics (PRCT) awards stock options and RSUs to EVP CTO Templin - Stock Titan
PROCEPT BioRobotics (PRCT) awards RSUs and stock options to CFO Kevin Waters - Stock Titan
Finanzdaten der Procept Biorobotics Corp-Aktie (PRCT)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.76%
0.38%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):